Ophthalmic Genetics and Gene Therapy

Gene therapy is an exploratory technique that employs genes to treat or prevent diseases. In near future, this technique may include a doctor replacing the mutated gene with a healthy copy of the gene to the patient in order to cure the abnormalities instead of surgery or drugs. Ophthalmic genetics is a branch of ophthalmology which refers to the field where the genetic background of disease is researched. Liber Congenital Amaris (LCA) is a hereditary genetic disease that causes childhood blindness. Scientists and doctors have treated this disease with the help of gene therapy.

 

  • Genetics of myopia development
  • Gene therapy
  • Usher syndrome
  • Familial exudative vitreal retinopathy
  • Retinoblastoma
  • Leber hereditary optic neuropathy (LHON)
  • Optic atrophy

Related Conference of Ophthalmic Genetics and Gene Therapy

August 28-29, 2024

5th International Conference on Euro Ophthalmology and Eye Surgery

Aix-en-Provence, France
September 12-13, 2024

5th International Conference on Optometry

Paris, France
October 10-11, 2024

34th World Congress on Ophthalmology and Optometry

Madrid, Spain
October 10-11, 2024

10th Global Ophthalmology Meeting

Madrid, Spain
October 14-15, 2024

5th International Conference on Ophthalmology and Optometry

Paris, France
October 17-18, 2024

24th Global Ophthalmologists Annual Meeting

London, UK
December 12-13, 2024

19th International Conference on Ophthalmology and Vision Science

Rome, Italy
February 24-25, 2025

9th World Congress on Eye and Vision

Madrid, Spain
March 17-18, 2025

39th European Ophthalmology Congress

Berlin, Germany
April 07-08, 2025

6th World congress on Ophthalmology and Optometry

Amsterdam, Netherlands
April 29-30, 2025

35th International Congress on Vision Science and Eye

Barcelona, Spain

Ophthalmic Genetics and Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in